AU2002221273A1 - Delayed and sustained release formulations and method of use thereof - Google Patents

Delayed and sustained release formulations and method of use thereof

Info

Publication number
AU2002221273A1
AU2002221273A1 AU2002221273A AU2127302A AU2002221273A1 AU 2002221273 A1 AU2002221273 A1 AU 2002221273A1 AU 2002221273 A AU2002221273 A AU 2002221273A AU 2127302 A AU2127302 A AU 2127302A AU 2002221273 A1 AU2002221273 A1 AU 2002221273A1
Authority
AU
Australia
Prior art keywords
delayed
sustained release
release formulations
formulations
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221273A
Inventor
Atul M. Mehta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002221273A1 publication Critical patent/AU2002221273A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
AU2002221273A 2000-10-26 2001-10-18 Delayed and sustained release formulations and method of use thereof Abandoned AU2002221273A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69590300A 2000-10-26 2000-10-26
US09/695,903 2000-10-26
PCT/US2001/032446 WO2002034240A2 (en) 2000-10-26 2001-10-18 Delayed and sustained release formulations and method of use thereof

Publications (1)

Publication Number Publication Date
AU2002221273A1 true AU2002221273A1 (en) 2002-05-06

Family

ID=24794914

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221273A Abandoned AU2002221273A1 (en) 2000-10-26 2001-10-18 Delayed and sustained release formulations and method of use thereof

Country Status (4)

Country Link
EP (1) EP1330239A2 (en)
JP (1) JP2004512298A (en)
AU (1) AU2002221273A1 (en)
WO (1) WO2002034240A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
DE102004014828A1 (en) * 2004-03-24 2005-11-03 Hexal Ag Pharmaceutical formulation, for oral administration, has a coating of film-forming polymers free of surfactants and anti-foaming agents
US8129359B2 (en) 2004-06-04 2012-03-06 Ethicon, Inc. Composition and method for treating post-surgical pain
US8377906B2 (en) 2004-06-04 2013-02-19 Ethicon, Inc. Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
FR2881049B1 (en) * 2005-01-24 2008-12-26 Vetoquinol Sa Sa MEDICAMENT FOR ORAL ADMINISTRATION COMPRISING A CYCLO-OXYGENASE-2 INHIBITOR, AND PROCESS FOR PREPARING THE SAME
US20110287091A1 (en) * 2009-01-22 2011-11-24 Abbot Healthcare Private Limited Chronotherapeutic pharmaceutical composition
US8945622B2 (en) 2009-03-09 2015-02-03 Council Of Scientific And Industrial Research Sustained release composition of therapeutic agent
WO2012059937A1 (en) * 2010-11-01 2012-05-10 Abbott Healthcare Private Limited Modifies release pharmaceutical compositons for nsaids
CN105816436B (en) * 2016-03-22 2019-10-22 广州共禾医药科技有限公司 A kind of Pantoprazole enteric-coated micro-pill, Pantoprazole enteric slow-release tablet agent and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520119A1 (en) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate New oral diclofenac composition
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation

Also Published As

Publication number Publication date
EP1330239A2 (en) 2003-07-30
WO2002034240A3 (en) 2002-10-10
WO2002034240A2 (en) 2002-05-02
JP2004512298A (en) 2004-04-22

Similar Documents

Publication Publication Date Title
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU7362301A (en) Bioadhesive compositions and methods of preparation and use
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
AU2001234437A1 (en) Deicing compositions and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2001294920A1 (en) Chrono delivery formulations and method of use thereof
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2001270573A1 (en) Sustained release preparations of quinolone antibiotics and method for preparation thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002221273A1 (en) Delayed and sustained release formulations and method of use thereof
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AU2003277876A1 (en) Modified release formulations of oxcarbazepine and derivatives thereof
AU2001292667A1 (en) Immunogenic composition of hepatitis c and methods of use thereof
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2003230320A1 (en) Sustained release formulation of protein and preparation method thereof
AU2001251352A1 (en) Brake cleaner compositions and method of using same
EP1263935A4 (en) Scytonemin and methods of using thereof